Fulcrum Therapeutics Inc (NASDAQ:FULC) currently has a daily average trading volume of 551.31K but it saw 390304 shares traded in last market. With a market cap of 343.31M USD, the company’s current market price of $6.36 came falling about -1.09 while comparing to the previous closing price of $6.43. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.13 and as low as $2.32. In the recent trading on the day, stock has struck highest price mark of $6.33 while lowest mark touched by it was $6.7401.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Leerink Partners which upgraded the stock as “Outperform” in its note to investors issued on May 23, 2025, recommending a price target of $12 for it. Cantor Fitzgerald upgraded its recommendation for the stock as a “Overweight” from “Neutral” on May 15, 2025 while assigning a price target of $10. H.C. Wainwright issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $17 and $4.
Over the week, FULC’s stock price is moving -6.88% down while it is -8.23% when we observe its performance for the past one month. Year-to-date it is 35.32% up and over the past year, the stock is showing a downside performance of -14.63%.
Currently, Fulcrum Therapeutics Inc’s total number of outstanding shares is 53.98M. Company’s return on investment (ROI) stands at -0.22% and return on equity (ROE) at -0.23%. Stock’s beta reads 2.42. Stock has a price to book (P/B) ratio of 1.50 while price to sale or P/S ratio amounts to 4.29. Its return on asset (ROA) is -0.21% on average.
